Retaglutide is a cutting-edge GLP-1 receptor agonist currently under research for the treatment of type 2 diabetes. This drug works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://sachinrsjj413785.designi1.com/59693243/trelaglutide-exploring-a-new-treatment-for-chronic-diseases